2,655 results
·
109ms
·
Sources: EU EUDAMED, US FDA
CANCER ANTIGEN 15-3
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 15-3
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 15-3
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 15-3
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 15-3
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 72-4
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 72-4
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 72-4
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 72-4
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 72-4
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 72-4
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 125
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 125
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 125
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 125
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 125
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 125
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 15-3
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 15-3
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market
CANCER ANTIGEN 15-3
Device
EU IVDD
·
Eu Ivd General
·Sansure Biotech Inc.·On the market